California BanCorp (BCAL) director awarded 1,048 RSUs
California BanCorp (BCAL) director Andrew J. Armanino reported an equity award in the form of restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
California BanCorp (BCAL) director Andrew J. Armanino reported an equity award in the form of restricted stock units. On 11/21/2025 he acquired 1,048 RSUs of California BanCorp common stock at a stated price of $0.00, reflecting compensation for his service on the company’s Board of Directors.
The filing shows that shares corresponding to these RSUs will be issued in full upon vesting on November 21, 2025. After this award, Armanino reports beneficial ownership of 11,361 common shares held directly and 212,578 common shares held indirectly through the Andrew J Armanino & Denise M Armanino Trust UA 6/2/1999.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,048 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Represents restricted stock units ("RSUs") issued to the Reporting Person as consideration for service on the Issuer's Board of Directors. Shares will be issued in full upon vesting on November 21, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did California BanCorp (BCAL) report in this Form 4?
What are the terms of the 1,048 RSUs reported for BCAL?
Is the BCAL Form 4 filing for a single reporting person or a group?
What is Andrew Armanino’s relationship to California BanCorp (BCAL)?
Does this BCAL Form 4 include any derivative securities transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.